Search research articles
Contact Us
Filters
Showing results (21-30 of 65) with videos related to
Page
of 7
Sort By:
Trials
|
August 15, 2023
The effect of a customised digital adherence tool on HIV treatment outcomes in young people living with HIV (YPLHIV) in Blantyre, Malawi: a protocol for a randomised controlled trial
Takondwa Charles Msosa, Iraseni Swai, Marion Sumari-de Boer, et al.
Trials
|
February 15, 2020
Pharmacokinetics, SAfety/tolerability, and EFficacy of high-dose RIFampicin in tuberculosis-HIV co-infected patients on efavirenz- or dolutegravir-based antiretroviral therapy: study protocol for an open-label, phase II clinical trial (SAEFRIF)
Ruth Nabisere, Joseph Musaazi, Paolo Denti, et al.
International Journal of Antimicrobial Agents
|
February 24, 2015
Pharmacokinetic/pharmacodynamic analysis of an intensified regimen containing rifampicin and moxifloxacin for tuberculous meningitis
Lindsey Te Brake, Sofiati Dian, Ahmad Rizal Ganiem, et al.
Chest
|
December 1, 2023
Safety and Efficacy of Clofazimine as an Alternative for Rifampicin in Mycobacterium avium Complex Pulmonary Disease Treatment: Outcomes of a Randomized Trial
Sanne M H Zweijpfenning, Rob Aarnoutse, Martin J Boeree, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)
|
July 10, 2024
The Effect of Real-Time Medication Monitoring-Based Digital Adherence Tools on Adherence to Antiretroviral Therapy and Viral Suppression in People Living With HIV: A Systematic Literature Review and Meta-Analysis
Takondwa Charles Msosa, Iraseni Swai, Rob Aarnoutse, et al.
Antimicrobial Agents and Chemotherapy
|
October 21, 2025
Cerebrospinal fluid penetration of cycloserine/terizidone and clofazimine in patients with pulmonary TB
Caryn M Upton, Jose M Calderin, Andreas H Diacon, et al.
Journal of Clinical Tuberculosis and Other Mycobacterial Diseases
|
June 17, 2026
Acetylator status-guided rapid reintroduction of isoniazid in tuberculosis patients with drug-induced hepatotoxicity
Cynthia van Arkel, Ralf Stemkens, Cécile Magis-Escurra, et al.
International Journal of Antimicrobial Agents
|
May 9, 2015
SILA-421 activity in vitro against rifampicin-susceptible and rifampicin-resistant Mycobacterium tuberculosis, and in vivo in a murine tuberculosis model
Gerjo J de Knegt, Irma A J M Bakker-Woudenberg, Dick van Soolingen, et al.
AIDS (London, England)
|
June 24, 2003
Therapeutic drug monitoring of nelfinavir and indinavir in treatment-naive HIV-1-infected individuals
David Burger, Patricia Hugen, Peter Reiss, et al.
Archives of Public Health = Archives Belges De Sante Publique
|
May 7, 2025
Engaging community pharmacy in tuberculosis case detection (ENHANCE): a study protocol for an implementation study in Indonesia
Ivan Surya Pradipta, Carla Florencia, Cut Ainul Mardhiyyah, et al.
Page
of 7
Search research articles
Search
Showing results (21-30 of 65) with videos related to
Sort By:
Page
of 7
Trials
|
August 15, 2023
The effect of a customised digital adherence tool on HIV treatment outcomes in young people living with HIV (YPLHIV) in Blantyre, Malawi: a protocol for a randomised controlled trial
Takondwa Charles Msosa, Iraseni Swai, Marion Sumari-de Boer, et al.
Trials
|
February 15, 2020
Pharmacokinetics, SAfety/tolerability, and EFficacy of high-dose RIFampicin in tuberculosis-HIV co-infected patients on efavirenz- or dolutegravir-based antiretroviral therapy: study protocol for an open-label, phase II clinical trial (SAEFRIF)
Ruth Nabisere, Joseph Musaazi, Paolo Denti, et al.
International Journal of Antimicrobial Agents
|
February 24, 2015
Pharmacokinetic/pharmacodynamic analysis of an intensified regimen containing rifampicin and moxifloxacin for tuberculous meningitis
Lindsey Te Brake, Sofiati Dian, Ahmad Rizal Ganiem, et al.
Chest
|
December 1, 2023
Safety and Efficacy of Clofazimine as an Alternative for Rifampicin in Mycobacterium avium Complex Pulmonary Disease Treatment: Outcomes of a Randomized Trial
Sanne M H Zweijpfenning, Rob Aarnoutse, Martin J Boeree, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)
|
July 10, 2024
The Effect of Real-Time Medication Monitoring-Based Digital Adherence Tools on Adherence to Antiretroviral Therapy and Viral Suppression in People Living With HIV: A Systematic Literature Review and Meta-Analysis
Takondwa Charles Msosa, Iraseni Swai, Rob Aarnoutse, et al.
Antimicrobial Agents and Chemotherapy
|
October 21, 2025
Cerebrospinal fluid penetration of cycloserine/terizidone and clofazimine in patients with pulmonary TB
Caryn M Upton, Jose M Calderin, Andreas H Diacon, et al.
Journal of Clinical Tuberculosis and Other Mycobacterial Diseases
|
June 17, 2026
Acetylator status-guided rapid reintroduction of isoniazid in tuberculosis patients with drug-induced hepatotoxicity
Cynthia van Arkel, Ralf Stemkens, Cécile Magis-Escurra, et al.
International Journal of Antimicrobial Agents
|
May 9, 2015
SILA-421 activity in vitro against rifampicin-susceptible and rifampicin-resistant Mycobacterium tuberculosis, and in vivo in a murine tuberculosis model
Gerjo J de Knegt, Irma A J M Bakker-Woudenberg, Dick van Soolingen, et al.
AIDS (London, England)
|
June 24, 2003
Therapeutic drug monitoring of nelfinavir and indinavir in treatment-naive HIV-1-infected individuals
David Burger, Patricia Hugen, Peter Reiss, et al.
Archives of Public Health = Archives Belges De Sante Publique
|
May 7, 2025
Engaging community pharmacy in tuberculosis case detection (ENHANCE): a study protocol for an implementation study in Indonesia
Ivan Surya Pradipta, Carla Florencia, Cut Ainul Mardhiyyah, et al.
Page
of 7